Cullinan Associates’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.56M | Sell |
42,219
-8,775
| -17% | -$512K | 0.21% | 82 |
|
|
2025
Q4 | $2.75M | Sell |
50,994
-4,625
| -8% | -$222K | 0.19% | 92 |
|
|
2025
Q3 | $2.51M | Sell |
55,619
-10,312
| -16% | -$482K | 0.16% | 97 |
|
|
2025
Q2 | $3.05M | Sell |
65,931
-3,989
| -6% | -$196K | 0.2% | 87 |
|
|
2025
Q1 | $4.26M | Sell |
69,920
-1,684
| -2% | -$98.2K | 0.3% | 71 |
|
|
2024
Q4 | $4.05M | Sell |
71,604
-20,628
| -22% | -$1.15M | 0.26% | 76 |
|
|
2024
Q3 | $4.82M | Sell |
92,232
-13,324
| -13% | -$625K | 0.27% | 76 |
|
|
2024
Q2 | $4.38M | Sell |
105,556
-3,782
| -3% | -$169K | 0.25% | 80 |
|
|
2024
Q1 | $5.93M | Sell |
109,338
-4,946
| -4% | -$252K | 0.33% | 62 |
|
|
2023
Q4 | $5.86M | Sell |
114,284
-26,085
| -19% | -$1.37M | 0.33% | 70 |
|
|
2023
Q3 | $8.15M | Buy |
140,369
+5,986
| +4% | +$367K | 0.47% | 52 |
|
|
2023
Q2 | $8.59M | Sell |
134,383
-29,439
| -18% | -$1.97M | 0.47% | 59 |
|
|
2023
Q1 | $11.4M | Buy |
163,822
+38,134
| +30% | +$2.69M | 0.66% | 43 |
|
|
2022
Q4 | $9.04M | Buy |
125,688
+14,710
| +13% | +$1.11M | 0.5% | 46 |
|
|
2022
Q3 | $7.89M | Buy |
110,978
+11,713
| +12% | +$850K | 0.5% | 54 |
|
|
2022
Q2 | $7.64M | Sell |
99,265
-2,457
| -2% | -$187K | 0.47% | 60 |
|
|
2022
Q1 | $7.43M | Sell |
101,722
-175,510
| -63% | -$11.8M | 0.39% | 72 |
|
|
2021
Q4 | $17.3M | Buy |
277,232
+2,200
| +0.8% | +$129K | 0.88% | 30 |
|
|
2021
Q3 | $16.3M | Buy |
275,032
+7,265
| +3% | +$478K | 0.9% | 29 |
|
|
2021
Q2 | $17.9M | Buy |
267,767
+15,534
| +6% | +$1.01M | 1% | 20 |
|
|
2021
Q1 | $15.9M | Buy |
252,233
+381
| +0.2% | +$23.7K | 0.92% | 19 |
|
|
2020
Q4 | $15.6M | Sell |
251,852
-13,057
| -5% | -$803K | 0.94% | 18 |
|
|
2020
Q3 | $16M | Sell |
264,909
-9,030
| -3% | -$543K | 1.03% | 15 |
|
|
2020
Q2 | $16.1M | Buy |
273,939
+645
| +0.2% | +$38.6K | 1.13% | 13 |
|
|
2020
Q1 | $15.2M | Sell |
273,294
-2,684
| -1% | -$164K | 1.25% | 12 |
|
|
2019
Q4 | $17.7M | Buy |
275,978
+7,794
| +3% | +$446K | 1.18% | 16 |
|
|
2019
Q3 | $13.6M | Buy |
268,184
+77,126
| +40% | +$3.62M | 0.97% | 18 |
|
|
2019
Q2 | $8.66M | Buy |
191,058
+58,901
| +45% | +$2.74M | 0.63% | 46 |
|
|
2019
Q1 | $6.3M | Buy |
132,157
+54,907
| +71% | +$2.74M | 0.47% | 59 |
|
|
2018
Q4 | $4.01M | Sell |
77,250
-4,150
| -5% | -$223K | 0.33% | 79 |
|
|
2018
Q3 | $5.05M | Sell |
81,400
-6,300
| -7% | -$374K | 0.37% | 77 |
|
|
2018
Q2 | $4.85M | Sell |
87,700
-30,500
| -26% | -$1.65M | 0.37% | 77 |
|
|
2018
Q1 | $7.48M | Sell |
118,200
-3,496
| -3% | -$225K | 0.57% | 41 |
|
|
2017
Q4 | $7.46M | Sell |
121,696
-6,500
| -5% | -$407K | 0.55% | 44 |
|
|
2017
Q3 | $8.17M | Sell |
128,196
-4,050
| -3% | -$236K | 0.63% | 43 |
|
|
2017
Q2 | $7.37M | Sell |
132,246
-2,250
| -2% | -$122K | 0.57% | 47 |
|
|
2017
Q1 | $7.31M | Buy |
134,496
+3,628
| +3% | +$199K | 0.6% | 49 |
|
|
2016
Q4 | $7.65M | Buy |
130,868
+41,772
| +47% | +$2.28M | 0.65% | 41 |
|
|
2016
Q3 | $4.8M | Sell |
89,096
-496,700
| -85% | -$31.9M | 0.41% | 70 |
|
|
2016
Q2 | $43.1M | Buy |
585,796
+88,700
| +18% | +$6.27M | 3.5% | 4 |
|
|
2016
Q1 | $31.8M | Sell |
497,096
-503,200
| -50% | -$31.7M | 2.71% | 4 |
|
|
2015
Q4 | $68.8M | Buy |
1,000,296
+5,840
| +0.6% | +$386K | 5.99% | 2 |
|
|
2015
Q3 | $58.9M | Sell |
994,456
-333,405
| -25% | -$21.2M | 5.38% | 2 |
|
|
2015
Q2 | $88.4M | Sell |
1,327,861
-26,940
| -2% | -$1.78M | 7.29% | 2 |
|
|
2015
Q1 | $87.4M | Sell |
1,354,801
-30,510
| -2% | -$1.91M | 6.78% | 2 |
|
|
2014
Q4 | $81.8M | Buy |
1,385,311
+323,008
| +30% | +$18.2M | 8.66% | 2 |
|
|
2014
Q3 | $54.4M | Buy |
1,062,303
+980,565
| +1,200% | +$49M | 6.19% | 4 |
|
|
2014
Q2 | $3.65M | Sell |
81,738
-881,455
| -92% | -$43.4M | 0.59% | 27 |
|
|
2014
Q1 | $50M | Sell |
963,193
-60,345
| -6% | -$3.21M | 5.69% | 5 |
|
|
2013
Q4 | $54.4M | Buy |
1,023,538
+891,300
| +674% | +$45.4M | 6.31% | 5 |
|
|
2013
Q3 | $6.12M | Buy |
132,238
+15,750
| +14% | +$691K | 0.82% | 22 |
|
|
2013
Q2 | $5.21M | Buy |
+116,488
| New | +$5.06M | 0.7% | 24 |
|
Other funds holding BMY
VCM
VPM
Cullinan Associates's BMY Position: Q1 2026 in Review
Cullinan Associates reduced its Bristol-Myers Squibb (BMY) stake by 17% in Q1 2026, selling an estimated $512K and leaving 42,219 shares worth $2.56M. The position accounts for 0.21% of the portfolio, ranked #82.
Cullinan Associates first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $88.4M in Q2 2015. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Cullinan Associates held 42,219 shares of Bristol-Myers Squibb worth $2.56M as of Q1 2026.
- Cullinan Associates sold 8,775 Bristol-Myers Squibb shares in Q1 2026, an estimated $512K.
- Bristol-Myers Squibb made up 0.21% of Cullinan Associates's portfolio in Q1 2026, its #82 holding.
- Cullinan Associates first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Cullinan Associates's Bristol-Myers Squibb position peaked at $88.4M in Q2 2015.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Cullinan Associates's 13F filing for Q1 2026, filed 1 May 2026.